comparemela.com

Latest Breaking News On - பிராந்திய தலைமையகம் - Page 10 : comparemela.com

BioNTech SE: BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore

(2) BioNTech to establish first regional hub in Asia Pacific region in Singapore Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats Expansion plan supported by the Singapore Economic Development Board (EDB) MAINZ, GERMANY, May 10, 2021 - BioNTech SE(Nasdaq: BNTX, BioNTech or the Company ) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech s growing pipeline of mRNA-based product candidates, as well as a rapid response production

Investegate |BioNTech SE Announcements | BioNTech SE: BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore

BioNTech SE BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore BioNTech to establish first regional hub in Asia Pacific region in Singapore Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats    Expansion plan supported by the Singapore Economic Development Board (EDB)   MAINZ, GERMANY, May 10, 2021 BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manu

BioNTech to establish regional HQ, mRNA manufacturing facility in Singapore

FILE PHOTO: A healthcare worker prepares a dose of the Pfizer/BioNTech coronavirus disease (COVID-19) vaccine, which was authorized by Canada to be used for children aged 12 to 15, at Woodbine Racetrack pop-up vaccine clinic in Toronto, Ontario, Canada May 5, 2021. REUTERS/Carlos Osorio SINGAPORE: BioNTech SE today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for southeast Asia in Singapore. The German biotechnology company also plans to establish a fully integrated messenger RNA (mRNA) manufacturing facility in the republic with support from the Singapore Economic Development Board. Having multiple nodes in our production network is an important strategic step in building out our global footprint and capabilities,” said its Chief Executive and Co-founder, Ugur Sahin, in its website.

BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore

Published: May 10, 2021 BioNTech to establish first regional hub in Asia Pacific region in Singapore Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats Expansion plan supported by the Singapore Economic Development Board (EDB) MAINZ, GERMANY, May 10, 2021 BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech’s growing pipeline of mRNA-based product candidates, a

Further Progress on the expansion of the OPW regional headquarters in Headford welcomed

Galway Bay FM 2 May 2021 print Galway Bay Fm Newsroom – The further progress on the expansion of the Office of Public Works (OPW) Regional Headquarters in Headford has been welcomed by independent TD Sean Canney. The works will include the refurbishment of the existing office and an extension in an investment expected to be in excess of €4.5 million. Deputy Canney welcomed the news of the progress, saying it was positive news for Headford and for the Region Deputy Canney said, “This is positive news as there will be local construction workers and sub-contractors employed during construction and the project will ensure that the OPW Regional Office serving Galway and Mayo will remain located permanently in Headford and consolidates the OPW presence in the town.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.